Efficacy and tolerability of pantoprazole versus ranitidine in the treatment of reflux esophagitis and the influence of Helicobacter pylori infection on healing rate

Diseases of the Esophagus

Volumn 15, Issue 1, 2002, Pages 50-56

  Meneghelli, U G ^a,k   Boaventura, S ^a   Moraes Filho, J P P ^a   Leitao O ^k   Ferrari Jr , A P ^b   Almeida, J R ^c   Magalhaes A F N ^d   Castro, L P ^e   Haddad, M T ^k   Tolentino, M ^f   Jorge, J L ^g   Silva, E ^h   Maguilnik, I ⁱ   Fischer, R ^j  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^d UNIVERSITY OF CAMPINAS   (Brazil)

^e FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^f HOSPITAL DE BASE   (Brazil)

^g HOSPITAL GOVERNADOR CELSO RAMOS   (Brazil)

^h Hospital Santa Isabel   (Brazil)

ⁱ HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^j ALTANA PHARMA AG   (Germany)

^k Byk Gulden Pharmaceuticals ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

LIVER ENZYME; PANTOPRAZOLE; RANITIDINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; ERUCTATION; ESOPHAGOSCOPY; EVALUATION; FEMALE; HEADACHE; HEALING; HEARTBURN; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONHUMAN; PAIN; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; REFLUX ESOPHAGITIS; SOMNOLENCE; SWALLOWING; SYMPTOM; TREATMENT FAILURE; VERTIGO;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; BENZIMIDAZOLES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ESOPHAGITIS, PEPTIC; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PROBABILITY; RANITIDINE; RISK ASSESSMENT; SULFOXIDES; TREATMENT OUTCOME; WOUND HEALING;

EID: 0036316996     PISSN: 11208694     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2050.2002.00225.x     Document Type: Article

References (27)

1. Relation between acid exposure and healing with omeprazole in patients with severe reflux esophagitis
2. Gastroesophageal reflux disease
3. Appropriate acid suppression for the management of gastroesophageal reflux disease
4. Gastroesophageal reflux disease
5. Management of gastro-oesophageal reflux disease in general practice
6. The role of proton pump inhibitors in the treatment of gastro-esophageal reflux disease
7. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: A meta-analysis
8. Interaction of proton pump inhibitors with cytochromes P450: Consequences for drug interactions
9. Lack of pantoprazole drug interactions in man: An updated review
10. Pharmacokinetics and metabolism of the proton pump inhibitor pantoprazole in man
11. Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders
12. Pantoprazole and omeprazole in the treatment of reflux esophagitis: A European multicenter study
13. Efficacy and tolerability of pantoprazole versus ranitidine and famotidine in patients with gastro-oesophageal reflux disease: Multicentre, open randomised, controlled studies
14. Pantoprazole: A new proton pump inhibitor in the management of upper gastrointestinal disease
15. Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole
16. Review article: The clinical influence of Helicobacter pylori in effective acid suppression-implications for the treatment of gastro-oesophageal reflux disease
17. The effect of Helicobacter pylori eradication on intragastric pH during dosing with lansoprazole or ranitidine
18. Treatment of reflux oesophagitis of moderate and severe grade with ranitidine or pantoprazole: Pharmacol Ther
19. The effects of oral doses of lansoprazole and omeprazole on gastric pH
20. Comparison of 24-h control of gastric acidity by three different dosages of pantoprazole in patients with duodenal ulcer
21. Intragastric pH and serum gastrin after one week treatment with pantoprazole, ranitidine or placebo in man
22. Effect of pantoprazole on 24-h Intragastric pH and serum gastrin in humans
23. Low-dose pantoprazole (20 mg) is effective for treatment of mild reflux oesophagitis
24. Curing the Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis
25. Does Helicobacter pylori affect the management of gastroesophageal reflux disease?
26. Intragastric pH during treatment with omeprazole: Role of Helicobacter pylori and H-pylori-associated gastritis
27. Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole